These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32850336)

  • 61. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis.
    Zeng X; Hu Z; Ke X; Tang H; Wu B; Wei X; Liu Z
    Cell Cycle; 2017; 16(22):2212-2219. PubMed ID: 28881158
    [TBL] [Abstract][Full Text] [Related]  

  • 63. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
    Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
    Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis.
    Liu XJ; Li SL; Li JS; Lu H; Yin LL; Zheng WF; Wang WC
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2624-2630. PubMed ID: 29771411
    [TBL] [Abstract][Full Text] [Related]  

  • 65. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 66. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells.
    Ou Y; Deng Y; Wang H; Zhang Q; Luo H; Hu P
    Front Med (Lausanne); 2021; 8():649279. PubMed ID: 33928106
    [No Abstract]   [Full Text] [Related]  

  • 68. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
    [TBL] [Abstract][Full Text] [Related]  

  • 69. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
    Yang Y; Dong MH; Hu HM; Min QH; Xiao L
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LncRNA HOXD-AS1 promotes melanoma cell proliferation and invasion by suppressing RUNX3 expression.
    Zhang H; Bai M; Zeng A; Si L; Yu N; Wang X
    Am J Cancer Res; 2017; 7(12):2526-2535. PubMed ID: 29312805
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
    Wang X; Yang B; She Y; Ye Y
    J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Knockdown of lncRNA C5orf66-AS1 inhibits osteosarcoma cell proliferation and invasion via miR-149-5p upregulation.
    Zhang H; Song J
    Oncol Lett; 2021 Nov; 22(5):757. PubMed ID: 34539861
    [TBL] [Abstract][Full Text] [Related]  

  • 74. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Long Non-Coding RNA
    Wu S; Ding L; Xu H; Gao J; Shao Y; Zhang S; Wei Z
    Onco Targets Ther; 2020; 13():7897-7906. PubMed ID: 32884284
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long noncoding RNA DLX6-AS1 targets miR-124-3p/CDK4 to accelerate Ewing's sarcoma.
    Lei X; Yang S; Yang Y; Zhang J; Wang Y; Cao M
    Am J Transl Res; 2019; 11(10):6569-6576. PubMed ID: 31737208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transcriptome sequencing of hepatocellular carcinoma uncovers multiple types of dysregulated ncRNAs.
    Zhang L; Wang C; Lu X; Xu X; Shi T; Chen J
    Front Oncol; 2022; 12():927524. PubMed ID: 36132143
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Aberrant methylation-mediated downregulation of lncRNA
    Zhao C; Liu J; Wu H; Hu J; Chen J; Chen J; Qiao F
    J Biol Res (Thessalon); 2020 Dec; 27():11. PubMed ID: 32607313
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exosome-derived lncRNA A1BG-AS1 attenuates the progression of prostate cancer depending on ZC3H13-mediated m6A modification.
    Yang Z; Luo Y; Zhang F; Ma L
    Cell Div; 2024 Feb; 19(1):5. PubMed ID: 38351022
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway.
    Di S; Bai R; Lu D; Chen C; Ma T; Zou Z; Zhang Z
    Cell Death Discov; 2022 May; 8(1):249. PubMed ID: 35513366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.